Recent Articles from GlobeNewswire

Vision Action Fund Awards 24 Governments $10M+ to Transform Basic Eye Care and Expand Reading Glasses Access
Awarded governments will make vision screening, specialist referral and reading glasses part of the health services people already use
By Vital Strategies · Via GlobeNewswire · November 2, 2026
FLNC ALERT: Bragar Eagel & Squire, P.C. Reminds Fluence Energy, Inc. Investors to Contact the Firm Regarding Their Rights Before November 30th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluence (FLNC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
ROSEN, THE FIRST FILING FIRM, Encourages Netcapital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NCPL
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · November 2, 2026
SAIC Announces Pricing of Upsized Offering of $500 Million in Senior Notes
RESTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence, and civilian agencies, announced today that it has priced an offering of $500 million aggregate principal amount of 6.75% senior notes due 2034 (the “Notes,” and such offering, the “Offering”). The Notes were priced at 100% of their principal amount and will be senior unsecured obligations of SAIC. The Offering is expected to close on or about November 13, 2026, subject to customary closing conditions. The Notes will be guaranteed on a senior unsecured basis by each of SAIC’s existing and future domestic subsidiaries that guarantee SAIC’s obligations under its credit agreement and certain other indebtedness, including its 5.875% Senior Notes due 2033.
By SAIC, Inc. · Via GlobeNewswire · November 2, 2026
Greenlane Appoints Peter Kampian to its Board of Directors
Experienced public company chief financial officer and director brings financial reporting and capital markets expertise
By Greenlane Holdings, Inc. · Via GlobeNewswire · November 2, 2026
Lotus Tech Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced that it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on October 28, 2026, indicating that the Company is not in compliance with the $1.00 minimum bid price requirement under the Nasdaq Listing Rules (the “Listing Rules”). Based on the closing bid price of the Company’s listed securities from September 16, 2026 to October 27, 2026, the Company has not met the minimum bid price requirement set forth in Listing Rule 5450(a)(1) during that period.
By Lotus Technology Inc. · Via GlobeNewswire · November 2, 2026
Churchill Capital Corp XI Shareholders Approve Business Combination with Agility Robotics
Approximately $465 million in expected gross capital to support Agility’s business plan and accelerate commercial deployments
By Agility Robotics, Inc · Via GlobeNewswire · November 2, 2026
Honeywell Aerospace Inc. Investors Have Until November 23rd to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Honeywell Aerospace (HONA) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
Vireo Growth Inc. Receives Federal DEA Registrations for Florida Medical Cannabis Dispensaries
MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading cannabis company and agricultural markets platform, today announced that it has received registrations from the U.S. Drug Enforcement Administration (“DEA”) for all 41 of its state-licensed medical cannabis dispensaries in Florida.
By Vireo Growth Inc. · Via GlobeNewswire · November 2, 2026
Ero Copper Reports Record Third Quarter 2026 Results
(all amounts in US dollars, unless otherwise noted)
By Ero Copper Corp. · Via GlobeNewswire · November 2, 2026
Vote Smart Empowers Human Judgment as AI Influences Politics
Elise Blum and Dr. Kyle Dell examine who selects the information behind AI-generated political answers and why citizens must retain the final judgment
By Vote Smart · Via GlobeNewswire · November 2, 2026
Osisko Gold Appoints Vice President, Construction Operations for the Cariboo Gold Project
TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the "Company") is pleased to announce the appointment of Mr. Cameron Carter as Vice President, Construction Operations of Barkerville Gold Mines Ltd., the Company's wholly-owned subsidiary, effective immediately. Mr. Carter will oversee construction execution currently underway at the Cariboo Gold Project (the "Project"), located in central British Columbia. Reporting directly to Sean Roosen, Chairman and CEO, he will work alongside JDS Energy & Mining Inc., the Project's principal construction management contractor.
By Osisko Gold Group Inc. · Via GlobeNewswire · November 2, 2026
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
Fort Lee, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today announced that it will host a conference call and webcast on Wednesday, November 4, 2026 at 8:00 AM ET to discuss recent business progress and financial results for the third quarter ended September 30, 2026. 
By Nuvectis Pharma, Inc. · Via GlobeNewswire · November 2, 2026
ACT Government City and Environment Directorate Builds on Seven Years of Smart Lighting Success with Itron and Omexom
Canberra Expands Its Smart Lighting Network Through the Upgrade of 16,000 Existing Streetlights Supporting Sustainability, Public Safety and Smart City Goals
By Itron, Inc. · Via GlobeNewswire · November 2, 2026
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on November 2, 2026, to three newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).
By Dianthus Therapeutics, Inc. · Via GlobeNewswire · November 2, 2026
Pulse Oil Corp. Announces Proposed Share Consolidation
VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Pulse Oil Corp. (“Pulse” or the "Corporation”) (TSXV: PUL) announces that it intends to complete a consolidation (the “Consolidation”) of its issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every twenty (20) pre-Consolidation Common Shares.
By Pulse Oil Corp. · Via GlobeNewswire · November 2, 2026
Qlik Named a Leader in the 2026 Gartner® Magic Quadrant™ for Data Integration Tools
The evaluation covered Qlik Talend Cloud®, Talend® Data Fabric, and Qlik Replicate® for Completeness of Vision and Ability to Execute
By Qlik Technologies, Inc. · Via GlobeNewswire · November 2, 2026
BETTER HOME & FINANCE INVESTOR DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Better Home & Finance Holding Company Investors to Contact the Firm Before November 20th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Better Home (BETR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
FCEL URGENT DEADLINE: FuelCell Energy, Inc. Investors Have Until November 10th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In FuelCell (FCEL) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
ROSEN, THE FIRST FILING FIRM, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TIGR
ROSEN, THE FIRST FILING FIRM, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TIGR
By The Rosen Law Firm PA · Via GlobeNewswire · November 2, 2026
Destination XL Group, Inc. Announces Date for 2026 Annual Meeting of Stockholders
CANTON, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG) (the “Company”), the leading integrated-commerce specialty retailer of Big + Tall men’s clothing and footwear, announced today that its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) will be held on Thursday, December 17, 2026. The meeting will be held at the Company’s corporate headquarters located at 555 Turnpike Street, Canton, Massachusetts 02021. The formal portion of the 2026 Annual Meeting will commence at 11:30 a.m. Eastern Time and will be held in person only, with no remote participation or streaming.
By Destination XL Group, Inc. · Via GlobeNewswire · November 2, 2026
Fortuna Advances Diamba Sud Gold Project Permitting in Senegal
VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to provide an update on its progress at the Diamba Sud gold project, Senegal.
By Fortuna Mining Corp. · Via GlobeNewswire · November 2, 2026
Guggenheim Investments Announces November 2026 Closed-End Fund Distributions
NEW YORK, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”).
UPDATE -- Leonardo DRS Selected by AV for U.S. Army’s Enduring-High Energy Laser Production Program
DRS will provide critical power and thermal management subsystems for a mobile counter-unmanned aircraft system capability
By Leonardo DRS, Inc. · Via GlobeNewswire · November 2, 2026
Air Methods Announces Inaugural Winner of Roy Morgan Legacy Award
Dr. Ira Blumen honored with award at Air Medical Transport Conference
By Air Methods · Via GlobeNewswire · November 2, 2026
LINCOLN EDUCATIONAL ALERT: Bragar Eagel & Squire, P.C. Urges Lincoln Educational Services Corp. Investors to Contact the Firm Before the November 10th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lincoln (LINC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
Telos Board Appoints Executive Vice President Mark Griffin as CEO; John B. Wood to Serve as Executive Chairman
ASHBURN, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that its Board of Directors has appointed Executive Vice President Mark Griffin as the company’s Chief Executive Officer, effective today. John B. Wood will transition from CEO to Executive Chairman, effective today.
By Telos Corporation · Via GlobeNewswire · November 2, 2026
Full House Resorts Announces Third Quarter Earnings Release Date
LAS VEGAS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Full House Resorts (NASDAQ: FLL) announced today that it will report its third quarter 2026 financial results on Thursday, November 5, 2026, followed by a conference call at 4:30 p.m. ET (1:30 p.m. PT). Investors can access the live audio webcast from the Company’s website at www.fullhouseresorts.com under the investor relations section. The conference call can also be accessed by dialing (201) 689-8470.
By Full House Resorts, Inc. · Via GlobeNewswire · November 2, 2026
MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
Webcast to highlight advancement of the randomized Phase 2 trial of agenT-797 in acute lung injury, the ARPA-H collaboration to advance deployable cell therapeutics, and new data released at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting
By MiNK Therapeutics · Via GlobeNewswire · November 2, 2026
California Resources Corporation Reports Third Quarter 2026 Financial and Operating Results
Raised Quarterly Dividend by 4% and Delivered 2% Quarter-over-Quarter Net Production Growth 
By California Resources Corporation · Via GlobeNewswire · November 2, 2026
Cabot Corporation Reports Fourth Quarter and Fiscal Year 2026 Results
Fourth Quarter 2026 Diluted earnings per share (“EPS”) of $1.25 and Adjusted EPS of $1.61 Fiscal Year 2026 Diluted EPS of $4.02 and Adjusted EPS of $6.42
By Cabot Corporation · Via GlobeNewswire · November 2, 2026
Carbon TerraVault Provides Third Quarter 2026 Update
Announced MOU with Bloom Energy to Advance 1 GW or More of Decarbonized Power in California
By Carbon TerraVault, LLC · Via GlobeNewswire · November 2, 2026
Athene Holding Ltd. Declares Fourth Quarter 2026 Preferred Stock Dividends
WEST DES MOINES, Iowa, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Athene announced that it has declared the following preferred stock dividends on its non-cumulative preferred stock (represented by depositary shares, each representing a 1/1,000th interest in a share of preferred stock), payable on December 30, 2026 to holders of record as of December 15, 2026.
By Athene Holding Ltd. · Via GlobeNewswire · November 2, 2026
USA Rare Earth Announces Date for Release of Third Quarter 2026 Results and Conference Call
STILLWATER, Okla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), today announced that it will release financial results for the quarterly period ended September 30, 2026, after U.S. markets close on Monday, November 9, 2026. Additionally, the Company will host a conference call that afternoon to discuss the results and related matters.
By USA Rare Earth, Inc. · Via GlobeNewswire · November 2, 2026
Montauk Renewables Schedules Third Quarter 2026 Conference Call for Monday, November 9, 2026, at 5:30 p.m. ET
PITTSBURGH, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk” or “the Company") (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas (“RNG”), will host a conference call and webcast on Monday, November 9, 2026, at 5:30 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2026. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the same day as the conference call and webcast.
By Montauk Renewables · Via GlobeNewswire · November 2, 2026
DBV Technologies to Participate in Upcoming November Investor Conferences
Châtillon, France, November 2, 2026
By DBV Technologies S.A. · Via GlobeNewswire · November 2, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:
By Olema Oncology · Via GlobeNewswire · November 2, 2026
California Resources Corporation Announces Strategic Collaboration with Bloom Energy to Advance Decarbonized Power Across California
Companies to Evaluate Scalable, Clean and Firm Power Solutions to Advance 1 GW or More of Decarbonized Power in California
By California Resources Corporation · Via GlobeNewswire · November 2, 2026
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today reported financial results for the third quarter ended September 30, 2026, together with business updates highlighting continued clinical, pipeline and platform execution.
By Recursion Pharmaceuticals · Via GlobeNewswire · November 2, 2026
NanoXplore Strengthens Leadership Team with Appointment of Veteran Public-Company Finance Executive Constantino Malatesta as Chief Financial Officer
MONTREAL, Nov. 02, 2026 (GLOBE NEWSWIRE) -- (TSX: GRA) (OTCQX: NNXPF) – NanoXplore Inc. (“NanoXplore” or the “Company”), a world leader in graphene production and graphene-enhanced materials, today announced the appointment of Constantino Malatesta as Chief Financial Officer (CFO), effective November 11, 2026.
By NanoXplore Inc. · Via GlobeNewswire · November 2, 2026
New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps
Denver, Colorado, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today announced new positive Phase 2 data from the ongoing TUPELO trial of REC-4881, an investigational, oral MEK1/2 inhibitor for familial adenomatous polyposis (FAP). The new analyses show that most patients had reductions in both the number of larger, higher-risk polyps and in lower GI polyp burden, building on the upper GI results announced on October 15, 2026. Together, these findings support the potential of REC-4881 as an oral therapy to address FAP across the GI tract. Lisa Boardman, M.D., a gastroenterologist and Professor of Medicine at Mayo Clinic, presented the results in a Presidential Plenary at the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) Annual Meeting in Denver, Colorado.
By Recursion Pharmaceuticals · Via GlobeNewswire · November 2, 2026
Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
CHESS Health’s Rewards Engine Named a Winner in Inaugural Behavioral Health Business Product of the Year Awards
Rewards Engine is the only contingency management platform recognized in awards voted on by behavioral health leaders
By CHESS Health · Via GlobeNewswire · November 2, 2026
Postal Realty Trust Declares Third Quarter 2026 Dividend
CEDARHURST, N.Y., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), a publicly traded REIT focused on acquiring and managing critical logistics infrastructure primarily leased to the US Postal Service (the “USPS”), announced today that its board of directors has approved a quarterly dividend on the Company’s Class A common stock in the amount of $0.245 per share. This represents a 1.0% increase from the third quarter 2025 dividend. The dividend will be payable on November 27, 2026 to stockholders of record as of the close of business on November 13, 2026.
By Postal Realty Trust, Inc. · Via GlobeNewswire · November 2, 2026
BOBBY BERK LAUNCHES CAMENA COLLECTIVE, A NEW PRIVATE-ESTATE HOSPITALITY BRAND IN PALM DESERT
The Emmy-winning designer and Queer Eye star brings his signature approach to design and well-being to two private desert estates
By Camena Collective · Via GlobeNewswire · November 2, 2026
Intuitive Appoints Aaron Martin to its Board of Directors
SUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Aaron Martin, President of Insurance at Humana, to its board of directors, effective January 1, 2027.
By Intuitive Surgical, Inc. · Via GlobeNewswire · November 2, 2026
Westlake Chemical Partners LP Announces Third Quarter 2026 Distribution
$0.4714 per unit distribution declared payable on December 1, 2026
By Westlake Chemical Partners LP · Via GlobeNewswire · November 2, 2026
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
NORTHFIELD, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, is scheduled to present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 3:30pm Greenwich Mean Time (GMT).
By Medline Inc. · Via GlobeNewswire · November 2, 2026
onsemi Reports Third Quarter 2026 Results
Earnings growth outpaces revenue growth by 4x year-over-year
By onsemi · Via GlobeNewswire · November 2, 2026
Steel Reef Announces Special Dividend
CALGARY, ALBERTA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Steel Reef Infrastructure Corp. (“Steel Reef”) today announced that its Board of Directors has declared a special cash dividend of $0.42 per common share, payable on November 16, 2026, to shareholders of record at the close of business on November 6, 2026.
By Steel Reef Infrastructure Corp. · Via GlobeNewswire · November 2, 2026
Sonoco to Modernize and Expand URB Production at Richmond, VA Mill
HARTSVILLE, S.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), the largest producer of uncoated recycled paperboard (URB) in North America, today announced plans to invest $40 million over the next two years to modernize and expand production of its Richmond, VA paperboard mill, reinforcing the Company’s commitment to operational excellence, product innovation and long-term growth. The investment will enhance the mill’s manufacturing capabilities, improve product quality and operating efficiency and increase annual production capacity by approximately 9,000 tons. The Richmond mill is a strategic asset within Sonoco’s integrated URB system, supplying paperboard used in the Company’s iconic paper can packaging and producing lightweight Tan Bending Chip (TBC) grades for a diverse customer base. “Richmond has long played an important role in supporting our Consumer and Industrial packaging businesses with quality paperboard that delivers value to our customers,” said Howard Coker, Sonoco’s President and Chief Executive Officer. “This investment demonstrates our commitment to strengthening Sonoco’s paperboard system through targeted, high-return projects that enhance efficiency, improve product performance and positions us to meet growing customer demand. By adding state-of-the-art capabilities, we will further improve the quality and consistency of our products while increasing capacity that supports long-term growth.” Construction is expected to begin in early 2027. The first phase of the project will focus on enhancing sheet formation, profile control, density and cleanliness while expanding the mill’s production capabilities. A second phase, targeted for completion by the end of 2028, will include investment in pulping operations, water systems, automation and employee experience improvements. The project will be executed with minimal production disruption, allowing the mill to maintain its current annual output of approximately 120,000 tons throughout construction. Sonoco’s Industrial Paper Packaging segment is North America’s largest producer of URB, operating 10 mills and 16 paper machines across the United States and Canada. Together, these facilities produce approximately 1.2 million tons of high-quality heavyweight and lightweight TBC paperboard annually, supporting a broad range of packaging applications and end markets.
By Sonoco Products Company · Via GlobeNewswire · November 2, 2026
Hain Celestial Announces Fiscal 2027 First Quarter Earnings Results Conference Call and Webcast
HOBOKEN, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, will release its fiscal first quarter results before the market opens on Monday, November 9, 2026. The company will host a conference call, which will be webcast, to discuss the results at 8:00 AM ET.
By The Hain Celestial Group, Inc. · Via GlobeNewswire · November 2, 2026
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.
By Myriad Genetics, Inc. · Via GlobeNewswire · November 2, 2026
Recursion Appoints Fred Hassan as Chair of the Board
Salt Lake City, UT, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today announced that its Board of Directors has appointed Fred Hassan as Chair, effective October 31, 2026Mr. Hassan arrives with a strong track record of more than four decades in the pharmaceutical industry. He has grown global businesses and led teams that brought multiple medicines through development, regulatory approval and commercial launch. As an example, the severely challenged Schering-Plough returned to sales growth, strong cash flow, and expanded the number of new molecular entities in Phase 3 development from three to eight.
By Recursion Pharmaceuticals · Via GlobeNewswire · November 2, 2026
Upwork Reports Third Quarter 2026 Financial Results
Lifted, an Upwork company, acquires WorkMotion, a leading employer of record (EOR) 
By Upwork Inc. · Via GlobeNewswire · November 2, 2026
onsemi to Acquire Ferric, Establishing Leadership in Power Delivery for Next-Generation AI Processors
Acquisition expands AI Data Center revenue opportunity 
By onsemi · Via GlobeNewswire · November 2, 2026
Bioventus Reports Third Quarter Financial Results
DURHAM, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for the three and nine months ended September 26, 2026.
By Bioventus, Inc. · Via GlobeNewswire · November 2, 2026
Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November
CAMBRIDGE, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in three upcoming fireside chats in November:
By Relay Therapeutics, Inc. · Via GlobeNewswire · November 2, 2026
OrthoPediatrics to Participate in Upcoming Conferences
WARSAW, Ind., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences, held in New York, NY.
By OrthoPediatrics Corp. · Via GlobeNewswire · November 2, 2026
EverQuote Announces Third Quarter 2026 Financial Results
CAMBRIDGE, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading provider of growth solutions for property and casualty, or P&C, insurance providers, today announced financial results for the third quarter ended September 30, 2026.
By EverQuote, Inc. · Via GlobeNewswire · November 2, 2026
Ethos Reports Third Quarter Fiscal Year 2026 Financial Results
AUSTIN, Texas, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the third quarter ended September 30, 2026.
By Ethos Technologies Inc · Via GlobeNewswire · November 2, 2026
SOLV Energy Expands High-Voltage Infrastructure Capabilities with Acquisition of ASB Energy Services
SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (Nasdaq: MWH) (“SOLV”), a leading provider of infrastructure services to the power industry, today announced it has completed the acquisition of ASB Energy Services (“ASB”), a Texas-based contractor specializing in substation foundations, civil construction, and battery energy storage system (BESS) infrastructure.
By SOLV Energy, Inc. · Via GlobeNewswire · November 2, 2026
Korsana Biosciences to Participate in Upcoming Investor Conferences
WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Korsana Biosciences, Inc. (“Korsana” or the “Company”) (Nasdaq: KRSA), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences.
By Korsana Biosciences · Via GlobeNewswire · November 2, 2026
Adeia Announces Third Quarter 2026 Financial Results
Dipti Vachani appointed as Chief Executive OfficerSigned multi-year license renewals with Charter and TCLReiterate confidence in long-term $600 million annual revenue outlook
By Adeia Inc. · Via GlobeNewswire · November 2, 2026
Abivax to Participate in Upcoming Fall Investor Conferences
Abivax to Participate in Upcoming Fall Investor Conferences
By Abivax · Via GlobeNewswire · November 2, 2026
Regeneron Announces Investor Conference Presentations
TARRYTOWN, N.Y., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · November 2, 2026
BBSI Opens Pittsburgh Branch, Expanding Business Services in Pennsylvania
VANCOUVER, Wash., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., announced the opening of its BBSI Pittsburgh branch in Canonsburg, Pennsylvania.
By Barrett Business Services Inc · Via GlobeNewswire · November 2, 2026
Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026
BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Monday, November 9, 2026, at 4:30 p.m. ET to report financial results for the third quarter ended September 30, 2026, and to provide a business update.
By Atea Pharmaceuticals, Inc. · Via GlobeNewswire · November 2, 2026
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2026 Results
MIAMI BEACH, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report third quarter 2026 financial results before market open on Friday, November 6, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.
By Airsculpt Technologies, Inc. · Via GlobeNewswire · November 2, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on October 31, 2026, the Compensation Committee of Candel's Board of Directors (the Board) granted to 4 new employees, stock options to purchase an aggregate of 107,600 shares of the Company's common stock, with a per share exercise price of $8.33.  
By Candel Therapeutics · Via GlobeNewswire · November 2, 2026
Bath & Body Works Gives A Thousand Wishes New Ways to Shine
The fragrance icon inspires two new scents, A Thousand Wishes Granted and A Thousand Crystal Wishes, a new solid perfume format and a holiday campaign featuring global fashion icon Valentina Ferrer
By Bath & Body Works, Inc. · Via GlobeNewswire · November 2, 2026
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on November 2, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with Nasdaq Listing Rule 5635(c)(4).
By C4 Therapeutics, Inc. · Via GlobeNewswire · November 2, 2026
Syndax Announces CFO Transition – Aaron A. Ondrey Appointed Chief Financial Officer
- Keith A. Goldan to retire as CFO and remain with the Company through year-end to support the transition -
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · November 2, 2026
Xenon to Report Q3 2026 Financial Results on November 9, 2026
VANCOUVER, BC and BOSTON, MA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced it will report its third quarter 2026 financial results and provide a business update after the close of U.S. financial markets on Monday, November 9, 2026.
By Xenon Pharmaceuticals Inc. · Via GlobeNewswire · November 2, 2026
Dianthus Therapeutics to Participate in Five Investor Conferences During November
NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in five investor conferences.
By Dianthus Therapeutics, Inc. · Via GlobeNewswire · November 2, 2026